Oscar Health, Inc. (NYSE:OSCR) Receives $21.56 Average Target Price from Analysts

Shares of Oscar Health, Inc. (NYSE:OSCR) have been given a consensus recommendation of “Hold” by the nine ratings firms that are presently covering the firm, MarketBeat reports. Two investment analysts have rated the stock with a sell recommendation, two have issued a hold recommendation, four have issued a buy recommendation and one has assigned a strong buy recommendation to the company. The average twelve-month target price among brokers that have issued a report on the stock in the last year is $21.56.

OSCR has been the subject of a number of recent analyst reports. UBS Group initiated coverage on Oscar Health in a research report on Monday, October 7th. They issued a “neutral” rating and a $23.00 price objective for the company. Jefferies Financial Group started coverage on Oscar Health in a report on Tuesday, December 10th. They issued an “underperform” rating and a $12.00 price target for the company. Bank of America downgraded shares of Oscar Health from a “neutral” rating to an “underperform” rating and cut their price objective for the company from $21.00 to $13.50 in a report on Wednesday, November 6th. Finally, Piper Sandler reaffirmed an “overweight” rating and issued a $28.00 price objective on shares of Oscar Health in a research report on Tuesday, September 10th.

Oscar Health Stock Up 4.4 %

NYSE:OSCR opened at $14.09 on Wednesday. The company’s 50-day simple moving average is $15.89 and its 200-day simple moving average is $17.42. The company has a debt-to-equity ratio of 0.26, a quick ratio of 0.73 and a current ratio of 0.73. Oscar Health has a fifty-two week low of $8.14 and a fifty-two week high of $23.79. The stock has a market capitalization of $3.48 billion, a P/E ratio of -234.79 and a beta of 1.63.

Oscar Health (NYSE:OSCR) last announced its earnings results on Thursday, November 7th. The company reported ($0.22) earnings per share for the quarter, missing the consensus estimate of ($0.20) by ($0.02). Oscar Health had a net margin of 0.35% and a return on equity of 2.79%. The firm had revenue of $2.42 billion during the quarter, compared to analyst estimates of $2.33 billion. During the same quarter last year, the business earned ($0.29) earnings per share. Oscar Health’s revenue was up 68.3% on a year-over-year basis. On average, equities analysts anticipate that Oscar Health will post -0.01 earnings per share for the current fiscal year.

Insider Buying and Selling

In other news, CAO Victoria Baltrus sold 8,078 shares of the business’s stock in a transaction dated Monday, December 2nd. The stock was sold at an average price of $18.08, for a total value of $146,050.24. Following the completion of the transaction, the chief accounting officer now owns 146,036 shares of the company’s stock, valued at $2,640,330.88. The trade was a 5.24 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, CFO Richard Scott Blackley sold 25,279 shares of the company’s stock in a transaction dated Monday, December 2nd. The stock was sold at an average price of $18.08, for a total value of $457,044.32. Following the completion of the sale, the chief financial officer now owns 881,841 shares in the company, valued at $15,943,685.28. The trade was a 2.79 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders bought 1,055,478 shares of company stock valued at $14,432,852 and sold 103,610 shares valued at $1,847,519. Corporate insiders own 25.11% of the company’s stock.

Hedge Funds Weigh In On Oscar Health

Several institutional investors have recently made changes to their positions in OSCR. Point72 Hong Kong Ltd acquired a new stake in Oscar Health in the second quarter valued at approximately $78,000. Quest Partners LLC purchased a new position in shares of Oscar Health during the 2nd quarter valued at approximately $93,000. KBC Group NV grew its stake in Oscar Health by 41.2% in the 3rd quarter. KBC Group NV now owns 4,552 shares of the company’s stock valued at $97,000 after acquiring an additional 1,328 shares during the period. Amalgamated Bank increased its holdings in Oscar Health by 27.7% in the 2nd quarter. Amalgamated Bank now owns 6,727 shares of the company’s stock worth $106,000 after acquiring an additional 1,458 shares in the last quarter. Finally, Optimum Investment Advisors acquired a new position in Oscar Health during the third quarter worth $142,000. 75.70% of the stock is owned by hedge funds and other institutional investors.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.